We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Bringing together industry, academia, the third sector and the NHS to tackle healthcare challenges such as dementia, cancer, mental health, obesity and addiction.
What we do Dementia and Neurodegeneration was identified as one of the key…
What we do Cancer was identified as one of the key healthcare missions in…
What we do The Obesity Mission was identified as one of the key healthcare…
What we do The health and wider societal costs to society in England of…
What we do Mental health was identified as one of the key healthcare…
Official statistics on the bioscience and health technology sector 2021 to 2022.
Main points The number of life sciences businesses operating in the UK has…
1. Introduction This background quality and user guide accompanies the…
The following post holders are given pre-release access 24 hours prior to…
This fund is to support businesses investing in life sciences manufacturing projects in the UK.
This notice sets out how we will use your personal data, and your rights.…
Annual data on the bioscience and health technology sector.
Joint government and industry investment will deliver more than 250 high-skilled jobs producing environmentally-friendly inhalers.
Annual data on the life science sector in the UK and other countries.
Data on the life sciences sector in the UK and other countries.
Official statistics on the bioscience and health technology sector 2021
Final report of the independent review of UK commercial clinical trials, and government response.
A £650 million war-chest to fire up the UK’s life sciences sector and drive forward the government’s priority to grow the economy has been unveiled by the Chancellor of the Exchequer Jeremy Hunt today 25 May 2023.
Four life sciences companies from across the UK will benefit from the first tranche of Life Sciences Innovative Manufacturing Fund (LSIMF) grants.
Update to the Life Sciences Council Joint Statement on Medical Devices Regulatory Reform.
Lord James O’Shaughnessy has been appointed to conduct an independent review into the UK commercial clinical trials landscape.
Life Sciences Council Joint Statement on a new agreement to accelerate the delivery of the future UK HealthTech regulatory system.
Patients will benefit from cutting-edge new treatments as the government introduces a Vaccine Taskforce style approach to tackling health challenges.
Data on the life science sector in the UK and other countries.
Following its success during the COVID-19 pandemic, the functions of the Vaccine Taskforce will be embedded as a permanent part of government structures.
UK Under-Secretary of State for Innovation and Swedish Minister for Education sign Life Sciences Memorandum of Understanding
The shared commitments set out how the genomics community across the UK will collaborate during 2022 to 2025 to progress the government’s vision for genomic healthcare.
Official statistics on the bioscience and health technology sector 2020
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.